Cardio Diagnostics Holdings Inc (CDIOW) is at the forefront of the medical technology industry, focusing on transforming cardiovascular care with its innovative diagnostic solutions. Utilizing proprietary algorithms and advanced genetic testing, the company enhances the accuracy of cardiovascular risk assessments, enabling personalized patient management strategies. With a strong commitment to data analytics and genomics, Cardio Diagnostics is well-positioned to capitalize on the growing demand for precision medicine, thereby promising improved clinical outcomes and significant growth potential in the evolving healthcare landscape.
| Revenue (TTM) | 16,560 |
| Gross Profit (TTM) | 16,560 |
| EBITDA | $-6.27M |
| Operating Margin | -66598.00% |
| Return on Equity | -65.60% |
| Return on Assets | -38.00% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $3.01 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 185.10% |
| Shares Outstanding | 0 |
| Float | $2.83M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |